Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Sorafenib (Bay 43-9006) and Docetaxel in Metastatic Prostate Cancer

NCT00619996 is registered in ClinicalTrials.gov with Italian Trial in Medical Oncology as lead sponsor.

NCT NCT00619996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Sorafenib (Bay 43-9006) and Docetaxel in Metastatic Prostate Cancer
Lead sponsor
Italian Trial in Medical Oncology
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
January 31, 2009
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer